Trial intelligence / Profile preview

Dexmedetomidine versus lidocaine as analgesic adjuvants during balanced general anesthesia for abdominal surgery

PACTR202109892575291Phase 3Completed

Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine and lidocaine in pain (2 arms). Primary endpoint: Total dose consumption of intraoperative opioids. Started Aug 2019; status: completed.

02

Drugs

dexmedetomidinelidocaine
03

Conditions

pain

Beyond the preview

Go deeper on PACTR202109892575291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202109892575291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call